Literature DB >> 17613606

Multiple sclerosis and brief moderate exercise. A randomised study.

O H Bjarnadottir1, A D Konradsdottir, K Reynisdottir, E Olafsson.   

Abstract

This is a randomised control study, to determine the effect of aerobic and strength exercise on physical fitness and quality of life in patients with mild multiple sclerosis (MS). Sixteen outpatients with definitive MS, aged 18-50, with an Expanded Disability Status Scale (EDSS) <4, completed the study. Every patient was evaluated according to physical fitness with peak oxygen consumption (V'O2peak), workload and anaerobic threshold; quality of life (SF-36); and degree of disability (EDSS). The patients were then randomised to an exercise group (EG) (n =6) or a control group (CG) (n = 10). The EG exercised three times a week for five weeks, and the CG did not change their habits regarding exercise. In the EG, the mean change in workload was 0.34 W/kg (95% confidence interval (CI): 0.09-0.58), the mean change in V'O2peak was 4.54 mL/kg per minute (95% CI: 1.65-7.44), and the mean change in anaerobic threshold was 0.32 L/min (95% CI: 0.08-0.57). There was a tendency towards improved quality of life, and no change was detected in the degree of disability. This study confirms that brief, moderate, aerobic exercise improves physical fitness in individuals with mild MS. No evidence was found for worsening of MS symptoms in association with exercises.

Entities:  

Mesh:

Year:  2007        PMID: 17613606     DOI: 10.1177/1352458506073780

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  18 in total

Review 1.  Rehabilitation interventions in multiple sclerosis: an overview.

Authors:  Serafin Beer; Fary Khan; Jürg Kesselring
Journal:  J Neurol       Date:  2012-07-08       Impact factor: 4.849

2.  Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis?

Authors:  Ulrik Dalgas; Egon Stenager
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

Review 3.  Response Heterogeneity With Exercise Training and Physical Activity Interventions Among Persons With Multiple Sclerosis.

Authors:  Jessica F Baird; Robert W Motl
Journal:  Neurorehabil Neural Repair       Date:  2018-12-26       Impact factor: 3.919

Review 4.  The benefits of exercise training in multiple sclerosis.

Authors:  Robert W Motl; Lara A Pilutti
Journal:  Nat Rev Neurol       Date:  2012-07-24       Impact factor: 42.937

Review 5.  Aerobic capacity in persons with multiple sclerosis: a systematic review and meta-analysis.

Authors:  Martin Langeskov-Christensen; Martin Heine; Gert Kwakkel; Ulrik Dalgas
Journal:  Sports Med       Date:  2015-06       Impact factor: 11.136

6.  The effects of a twelve-week home walking program on cardiovascular parameters and fatigue perception of individuals with multiple sclerosis: a pilot study.

Authors:  E Lynne Geddes; Ellen Costello; K Raivel; R Wilson
Journal:  Cardiopulm Phys Ther J       Date:  2009-03

Review 7.  Exercise therapy for fatigue in multiple sclerosis.

Authors:  Martin Heine; Ingrid van de Port; Marc B Rietberg; Erwin E H van Wegen; Gert Kwakkel
Journal:  Cochrane Database Syst Rev       Date:  2015-09-11

8.  Effects of a Short Physical Exercise Intervention on Patients with Multiple Sclerosis (MS).

Authors:  Arno Kerling; Karin Keweloh; Uwe Tegtbur; Momme Kück; Lena Grams; Hauke Horstmann; Anja Windhagen
Journal:  Int J Mol Sci       Date:  2015-07-10       Impact factor: 5.923

9.  The role of exercise in modifying outcomes for people with multiple sclerosis: a randomized trial.

Authors:  Nancy E Mayo; Mark Bayley; Pierre Duquette; Yves Lapierre; Ross Anderson; Susan Bartlett
Journal:  BMC Neurol       Date:  2013-06-28       Impact factor: 2.474

10.  Getting the balance right: a randomised controlled trial of physiotherapy and Exercise Interventions for ambulatory people with multiple sclerosis.

Authors:  Susan Coote; Maria Garrett; Neasa Hogan; Aidan Larkin; Jean Saunders
Journal:  BMC Neurol       Date:  2009-07-16       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.